Robert Ross: I am thrilled to announce the launch of Clasp Therapeutics
Robert Ross, Chief Executive Officer at Clasp Therapeutics, announced on LinkedIn:
“I am thrilled to announce the launch of Clasp Therapeutics and to be part of a hardworking and dedicated team that will generate meaningful impact for people by transforming what is possible in immuno-oncology. Based on the brilliant work of our scientific founders Bert Vogelstein and Drew Pardoll, our T cell engagers have the potential to achieve high-precision anti-tumor activity without off-target reactivity, thus extending the number of patients and hard-to-treat tumor types we can reach with immune-directed therapies.
I want to thank our founders, our team, and our many investors for building Clasp from the ground up, and I look forward to what we can collectively achieve for patients.”
Source: Robert Ross/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023